Cargando…

Risk of fracture among patients with polymyalgia rheumatica and giant cell arteritis: a population-based study

BACKGROUND: Glucocorticoids are associated with increased fracture risk and are the mainstay of treatment in polymyalgia rheumatica (PMR) and giant cell arteritis (GCA). However, fracture risk in these conditions has not been previously quantified. The aim of this study was to quantify the risk of f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Paskins, Zoe, Whittle, Rebecca, Sultan, Alyshah Abdul, Muller, Sara, Blagojevic-Bucknall, Milica, Helliwell, Toby, Hider, Samantha, Roddy, Edward, Mallen, Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5761155/ https://www.ncbi.nlm.nih.gov/pubmed/29316928 http://dx.doi.org/10.1186/s12916-017-0987-1

Ejemplares similares

Comorbidities in polymyalgia rheumatica: a systematic review
por: Partington, Richard, et al.
Publicado: (2018)

Possible giant cell arteritis symptoms are common in newly diagnosed patients with Polymyalgia Rheumatica: results from an incident primary care PMR cohort
por: Masson, William, et al.
Publicado: (2017)

The availability of health information to patients with newly diagnosed polymyalgia rheumatica: results from the Polymyalgia Rheumatica (PMR) Cohort study
por: Tshimologo, Maatla, et al.
Publicado: (2018)

Polymyalgia rheumatica: diagnosis, prescribing, and monitoring in general practice
por: Helliwell, Toby, et al.
Publicado: (2013)

Fragility fractures and prescriptions of medications for osteoporosis in patients with polymyalgia rheumatica: results from the PMR Cohort Study
por: Sokhal, Balamrit Singh, et al.
Publicado: (2021)

Is cancer associated with polymyalgia rheumatica? A cohort study in the General Practice Research Database
por: Muller, Sara, et al.
Publicado: (2014)

The epidemiology of polymyalgia rheumatica in primary care: a research protocol
por: Muller, Sara, et al.
Publicado: (2012)

Examining management and research priorities in patients with polymyalgia rheumatica: a primary care questionnaire survey
por: Morton, Chris, et al.
Publicado: (2019)

The association of pain and stiffness with fatigue in incident polymyalgia rheumatica: baseline results from the polymyalgia rheumatica cohort study
por: Prior, J.A., et al.
Publicado: (2019)

Is Tocilizumab Effective and Safe in Polymyalgia Rheumatica and Giant-Cell Arteritis With Polymyalgia Rheumatica?
por: Farinango, Michelle, et al.
Publicado: (2022)

Long-term use of glucocorticoids for polymyalgia rheumatica: follow-up of the PMR Cohort Study
por: Muller, Sara, et al.
Publicado: (2022)

Longitudinal clusters of pain and stiffness in polymyalgia rheumatica: 2-year results from the PMR Cohort Study
por: Muller, Sara, et al.
Publicado: (2020)

The impact of polymyalgia rheumatica on intimate sexual relationships: findings from the PMR Cohort Study
por: Muller, Sara, et al.
Publicado: (2022)

Characterising those with incident polymyalgia rheumatica in primary care: results from the PMR Cohort Study
por: Muller, Sara, et al.
Publicado: (2016)

Optimal management of giant cell arteritis and polymyalgia rheumatica
por: Charlton, Rodger
Publicado: (2012)

Genetic epidemiology: Giant cell arteritis and polymyalgia rheumatica
por: Gonzalez-Gay, Miguel A
Publicado: (2001)

Giant Cell Arteritis and Polymyalgia Rheumatica: 2016 Update
por: Nesher, Gideon, et al.
Publicado: (2016)

Liver involvement in polymyalgia rheumatica and giant cell arteritis
por: Hysa, Elvis, et al.
Publicado: (2020)

Association of Polymyalgia Rheumatica With Socioeconomic Status in Primary Care: A Cross-Sectional Observational Study
por: Hayward, Richard A, et al.
Publicado: (2014)

Giant cell arteritis with polymyalgia rheumatica on FDG‐PET/CT
por: Baba, Akira, et al.
Publicado: (2017)

Familial aggregation of longevity in giant cell arteritis and polymyalgia rheumatica
por: Milchert, Marcin, et al.
Publicado: (2020)

Predictive Factors of Giant Cell Arteritis in Polymyalgia Rheumatica Patients
por: Ramon, André, et al.
Publicado: (2022)

Incident acute pseudogout and prior bisphosphonate use: Matched case–control study in the UK-Clinical Practice Research Datalink
por: Roddy, Edward, et al.
Publicado: (2017)

Giant Cell Arteritis Mimicking Polymyalgia Rheumatica: A Challenging Diagnosis
por: Ohta, Ryuichi, et al.
Publicado: (2022)

Metabolic bone health considerations in giant cell arteritis and polymyalgia rheumatica
por: Low, Candice, et al.
Publicado: (2023)

Association between characteristics of pain and stiffness and the functional status of patients with incident polymyalgia rheumatica from primary care
por: Cawley, A., et al.
Publicado: (2017)

Associations between polymyalgia rheumatica and giant cell arteritis and 12 cardiovascular diseases
por: Pujades-Rodriguez, Mar, et al.
Publicado: (2016)

Prognostic impacts of glucocorticoid treatment in patients with polymyalgia rheumatica and giant cell arteritis
por: Emamifar, Amir, et al.
Publicado: (2021)

What non-pharmacological treatments do people with polymyalgia rheumatica try: results from the PMR Cohort Study
por: Weddell, Jake, et al.
Publicado: (2021)

Patients' views on the causes of their polymyalgia rheumatica: a content analysis of data from the PMR Cohort Study
por: Tshimologo, Maatla, et al.
Publicado: (2017)

Polymyalgia rheumatica
por: Rosenberg, Hans, et al.
Publicado: (2021)

Interleukin-6: a promising target for the treatment of polymyalgia rheumatica or giant cell arteritis?
por: Toussirot, Éric, et al.
Publicado: (2016)

Genetic Predispositions of Glucocorticoid Resistance and Therapeutic Outcomes in Polymyalgia Rheumatica and Giant Cell Arteritis
por: Smutny, Tomas, et al.
Publicado: (2019)

The prevalence of giant cell arteritis and polymyalgia rheumatica in a UK primary care population
por: Yates, Max, et al.
Publicado: (2016)

Antimitochondrial Antibodies and Primary Biliary Cholangitis in Patients with Polymyalgia Rheumatica/Giant Cell Arteritis
por: Manzo, Ciro, et al.
Publicado: (2021)

Polymyalgia rheumatica and giant cell arteritis with intracranial involvement postvaccination anti-COVID-19
por: Arias, Manuel, et al.
Publicado: (2022)

Aberrant phenotype of circulating antigen presenting cells in giant cell arteritis and polymyalgia rheumatica
por: Reitsema, Rosanne D., et al.
Publicado: (2023)

Evaluating on-line health information for patients with polymyalgia rheumatica: a descriptive study
por: Vivekanantham, Arani, et al.
Publicado: (2017)

Challenges of diagnosis and management of giant cell arteritis in general practice: a multimethods study
por: Helliwell, Toby, et al.
Publicado: (2018)

Widespread headache as the first clinical manifestation of giant cell arteritis in patients affected by polymyalgia rheumatica
por: Manzo, Ciro
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_eura3nvappnf1m7si4v1m7lasr